查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1864599

按產品類型、材料類型、技術、應用、最終用戶和分銷管道分類的醫藥永續設備市場－2025-2032年全球預測

Sustainable Devices in Pharmaceutical Market by Product Type, Material Type, Technology, Application, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，醫藥永續設備市場將成長至 670.9 億美元，複合年成長率為 19.42%。

關鍵市場統計數據
基準年 2024 162.1億美元
預計年份：2025年 193.6億美元
預測年份 2032 670.9億美元
複合年成長率 (%) 19.42%

建構框架，探討永續醫療設備應用對製藥業產品設計、供應鏈韌性和監管合規性的緊迫性和策略性影響

隨著永續性從企業目標轉變為營運要務，醫療器材產業正經歷一場意義深遠的變革時期。新的監管要求、對產品全生命週期影響的日益關注以及不斷演進的醫療系統採購標準，都迫使製造商和供應商重新思考產品設計、材料採購和廢棄物管理策略。同時，醫療專業人員和患者也要求醫療器材在維持和提升安全性、易用性和治療效果的同時，有助於減少對環境的影響。

循環設計、數位化製造和不斷發展的採購標準如何共同改變製藥業的產品開發、生產地點和供應商策略

加速推動醫療器材的永續性並非漸進式演進，而是一系列變革性的轉變，正在重塑研發、生產和商業化流程。價值導向設計原則的適用範圍正在擴展，除了臨床和成本考量之外，還納入了生命週期性能指標，鼓勵多學科團隊從概念到商業化的整個過程中將環境標準納入產品需求。人工智慧和物聯網監控等數位技​​術正被應用於最佳化材料使用、預測性維護滅菌系統以及降低生產線的消費量。

高關稅對醫療器材價值鏈中製造商和供應商的影響：高關稅對採購、供應鏈韌性和營運選擇的影響

美國將於2025年實施的高關稅對支持製藥設備生產的全球供應商和契約製造製造商產生了疊加效應。關稅帶來的成本壓力使得依賴某些進口零件變得難以為繼，迫使企業重新評估其籌資策略，並對滅菌設備零件、品管設備和特種聚合物等關鍵材料的總到岸成本（TLC）進行建模。因此，採購部門正在加快討論供應商多元化、合格的國內採購以及雙重採購安排，以分散風險並確保臨床供應的連續性。

針對永續醫療設備策略的深度細分分析：關聯產品原型、材料科學選擇、底層技術、應用路徑、購買者類型和分銷模式

這項細分分析揭示了影響永續醫療設備策略的設計、材料、技術、應用、最終用戶和分銷管道等諸多因素的組合。所考慮的產品類型包括：給藥裝置，例如自動注射器、吸入器、預填充式注射器和經皮吸收貼片；物聯網和監測系統，包括資料分析平台和感測器解決方案；生產設備，從包衣機到製粒系統和壓平機片機；包裝設備（泡殼和瓶裝填充系統、裝盒和袋裝解決方案）；品管設備（層析法系統、光譜儀）；以及滅菌設備（高壓釜、環氧乙烷滅菌器和伽馬射線輻照系統）。對於吸入器而言，乾粉吸入器和定量吸入器之間的設計差異會顯著影響材料選擇和廢物處理方法。同時，泡殼包裝機和瓶裝灌裝機的配置也各不相同，從多通道到單通道，從在線連續式到旋轉式。

區域法規結構、採購實踐和製造生態系統如何影響美洲、歐洲、中東和非洲以及亞太地區永續醫療設備設計的採用

區域趨勢正在影響永續醫療器材創新技術的應用、監管預期和投資重點。在美洲，法規結構和採購慣例越來越注重可驗證的環境績效和供應鏈透明度，促使製造商試點循環包裝，並投資建設先進的滅菌和品管設施，以減少耗材的使用。北美臨床網路和大型醫院系統通常是那些檢驗在保持臨床療效的同時減少環境影響的醫療器材的早期採用者。

供應商夥伴關係、能力驅動型投資和策略交易正在重新定義醫療設備製造商、合約製造商和優質設備供應商之間的競爭優勢。

供應商和原始設備製造商 (OEM) 之間的競爭格局正受到永續性和臨床可靠性雙重壓力的重塑。領先的醫療設備製造商正投資組建設計團隊，整合材料科學、法規策略和人體工學，以推動產品開發，從而滿足環境和臨床要求。隨著企業尋求加快新材料的認證週期並降低供應風險，聚合物創新者、自動化專家和滅菌設備供應商之間的策略聯盟日益普遍。

為經營團隊提供可操作的策略性舉措，以透過設計階段性措施、供應商多元化、數位化品質系統和試驗計畫來實施永續性，從而加速其落地實施。

產業領導者應優先採取以下切實可行的步驟，將永續性措施轉化為競爭優勢：首先，將環境績效指標納入產品需求規範和設計流程，在考慮臨床和易用性目標的同時，同等重視材料選擇、可回收性和生命週期影響。其次，透過與聚合物創新者和積層製造技術專家簽訂共同開發契約，加速替代材料和製造技術的合格，縮短產品檢驗生產週期。

調查方法概述：透過訪談、技術諮詢、價值鏈圖繪製、生命週期評估原則和情境規劃等方法，獲得嚴謹而實用的見解。

本報告整合了一手和二手研究，以確保研究結果的可靠性和可重複性，從而為策略決策提供支援。一手研究包括對醫療設備製造商 (OEM)、契約製造、材料供應商和機構採購部門的高階主管進行結構化訪談，以及與監管和品質保證專家進行技術諮詢。這些定性研究結果與已發布的監管指南、專利、滅菌和包裝標準以及關於可生物分解聚合物和積層製造的同行評審文獻進行了三角驗證。

該評估報告強調了採取綜合永續發展措施的策略必要性，以確保臨床完整性、營運韌性和長期競爭優勢。

永續醫療設備既是挑戰也是機會。它們既需要減少對環境的影響，又需要確保安全性、無菌性和治療效果。能夠全面協調設計、採購、生產和監管策略的公司，不僅能夠滿足相關人員的期望，還能透過減少廢棄物、最佳化能源利用和實現彈性採購來提高營運效率。未來的道路需要嚴謹的實驗、對基礎技術的定向投資，以及供應商、監管機構和大型機構採購商之間的合作。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 將可生物分解的微針陣列整合到自我給藥系統中
  • 推出可重複使用、連網的吸入器，具備智慧劑量監測和分析功能。
  • 利用植物來源聚合物開發可堆肥一次性注射器
  • 推出閉合迴路胰島素幫浦
  • 擴大口服固體製劑的再生塑膠包裝
  • 推出一款採用可再生能源運作的模組化製藥生產單元
  • 在活性藥物原料藥生產中使用先進的排放捕集系統

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依產品類型分類的醫藥永續設備市場

  • 餵食裝置
    • 自動注射器
    • 吸入器
      • 乾粉
      • 固定劑量
    • 預填充式注射器
    • 經皮貼劑
  • 物聯網和監控系統
    • 數據分析平台
    • 感應器
  • 製造設備
    • 塗佈機
    • 造粒系統
    • 壓平機
  • 包裝設備
    • 泡殼包裝機
      • 多車道
      • 單行道
    • 瓶裝灌裝機
      • 在線連續
      • 旋轉式
    • 裝盒機
    • 小袋包裝機
  • 品管設備
    • 層析法系統
    • 光譜儀
  • 消毒器
    • 高壓釜
    • 環氧乙烷滅菌器
    • 伽瑪射線輻照系統

9. 依材料類型分類的製藥永續設備市場

  • 可生物分解聚合物
    • PBAT
    • PHA
    • PLA
  • 複合材料
  • 玻璃
  • 金屬
  • 回收塑膠

10. 按技術分類的製藥永續設備市場

  • 3D列印
    • 熔融沈積成型
    • 選擇性雷射燒結
    • 立體光刻技術
  • 人工智慧
  • 自動化
  • 物聯網賦能
  • 奈米科技

第11章：按應用分類的製藥永續設備市場

  • 低溫運輸管理
  • 藥物遞送
    • 吸入
      • 乾粉
      • 計量噴霧型
    • 腸外
      • 自動注射器
      • 預填充式注射器
  • 製藥生產
  • 藥品包裝
    • 初級包裝
      • 泡殼包裝
      • 瓶子
    • 二級包裝
      • 紙盒
      • 收縮膜
  • 品管

第12章：依最終用戶分類的醫藥永續設備市場

  • 契約製造組織
  • 合約研究機構
  • 醫院和診所
  • 製藥公司
  • 研究所

13. 按分銷管道分類的醫藥永續設備市場

  • 直銷
  • 批發商
  • 電子商務

14. 各地區醫藥永續設備市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 依組別分類的醫藥永續設備市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

16. 各國醫藥永續設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Merck KGaA
    • Sartorius AG
    • Corning Incorporated
    • Eppendorf AG
    • GEA Group Aktiengesellschaft
    • Alfa Laval AB
    • IMA SpA
    • Syntegon Technology GmbH
Product Code: MRR-6360D86E7072

The Sustainable Devices in Pharmaceutical Market is projected to grow by USD 67.09 billion at a CAGR of 19.42% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 16.21 billion
Estimated Year [2025] USD 19.36 billion
Forecast Year [2032] USD 67.09 billion
CAGR (%) 19.42%

Framing the urgency and strategic consequences of sustainable device adoption across product design, supply chain resilience, and regulatory engagement in pharmaceuticals

The pharmaceutical device landscape is undergoing a profound shift as sustainability moves from a corporate aspiration to an operational imperative. New regulatory expectations, rising attention to lifecycle impacts, and evolving procurement criteria from health systems are compelling manufacturers and suppliers to rethink product architecture, materials sourcing, and end-of-life strategies. At the same time, clinicians and patients demand devices that maintain or improve safety, usability, and therapeutic fidelity while contributing to reduced environmental footprints.

Transitioning legacy production lines and entrenched supply relationships requires deliberate strategy and cross-functional coordination. Design teams must reconcile competing constraints: regulatory evidence, sterility requirements, and material performance versus recyclability, biodegradability, and lower carbon intensity. Meanwhile, operations and procurement must secure resilient supply chains for next-generation materials and advanced manufacturing technologies such as additive manufacturing and IoT-enabled quality systems.

This introduction frames the remainder of the executive summary by outlining the structural drivers of change, the practical trade-offs faced by manufacturers, and the types of capabilities that will determine competitive winners. It also highlights the central role that collaborative pilots, targeted investments in automation and analytics, and proactive regulatory engagement play in accelerating adoption of sustainable devices across clinical and commercial pathways.

How circular design, digital manufacturing, and evolving procurement standards are jointly transforming product development, production footprints, and supplier strategies in pharmaceuticals

Accelerating sustainability in pharmaceutical devices is not an incremental evolution; it represents a set of transformative shifts that are reshaping R&D, manufacturing, and commercialization. Design-to-value principles are expanding to include lifecycle performance metrics alongside clinical and cost considerations, prompting interdisciplinary teams to embed environmental criteria into product requirements from concept through commercialization. Digital technologies such as artificial intelligence and IoT-enabled monitoring are being deployed to optimize material usage, predict maintenance of sterilization systems, and reduce energy intensity across production lines.

Manufacturing footprints are re-evaluated as firms consider nearshoring and modular production to reduce scope 3 emissions and improve supply continuity. At the same time, materials science advances-particularly in biodegradable polymers, composite materials, and recycled plastics-are enabling alternative packaging and component strategies while demanding new validation approaches. Quality control ecosystems are evolving to incorporate analytics-driven inspection and non-destructive testing that preserve product integrity while reducing waste of in-process goods.

These shifts are reinforced by changing procurement behaviors among large institutional buyers who increasingly solicit environmental performance data, and by investors who reward measurable sustainability plans. As a result, companies that integrate circular design, digital manufacturing, and robust lifecycle analytics will unlock operational efficiencies and meet the heightened expectations of regulators, payers, and end users.

Implications of elevated tariffs on procurement, supply resiliency, and operational choices for manufacturers and suppliers in the pharmaceutical device value chain

The introduction of elevated tariff measures in the United States during 2025 has created compounding effects for global suppliers and contract manufacturers supporting pharmaceutical device production. Tariff-driven cost pressure has made reliance on certain imported components less tenable, prompting companies to revisit sourcing strategies and to model the total landed cost of critical inputs including sterilization equipment parts, quality control instruments, and specialized polymers. Consequently, procurement teams have accelerated conversations about supplier diversification, qualified domestic sourcing, and dual-sourcing arrangements to mitigate exposure and ensure continuity of clinical supply.

In response, some manufacturers have initiated near-term operational adjustments such as reconfiguring logistics to utilize alternative ports or transport modalities, renegotiating long-term supply contracts to include tariff pass-through clauses, and advancing local content in new product specifications. These tactical responses are often combined with strategic investments in automation and vertical integration to offset higher input costs and to protect gross margins while preserving compliance and performance standards.

Moreover, the tariff environment has amplified the need for robust regulatory and customs expertise as product classifications and tariff codes intersect with medical device regulations. Companies that proactively engage cross-functional teams-legal, trade compliance, procurement, and regulatory affairs-can better forecast operational impacts, structure resilient supplier networks, and sequence capital projects to maintain competitiveness amid evolving trade policies.

Deep segmentation insight connecting product archetypes, material science choices, enabling technologies, application pathways, buyer types, and distribution models for sustainable device strategies

Segmentation analysis reveals the breadth of design, material, technological, application, end user, and distribution permutations shaping sustainable device strategies. Product Type considerations span Delivery Devices such as auto-injectors, inhalers, prefilled syringes, and transdermal patches; IoT and monitoring systems that include data analytics platforms and sensor solutions; Manufacturing Equipment ranging from coating machines to granulation systems and tablet presses; Packaging Equipment including blister and bottle filling systems, cartoning, and sachet packaging solutions; Quality Control Equipment such as chromatography systems and spectrometers; and Sterilization Equipment including autoclaves, ethylene oxide sterilizers, and gamma irradiation systems. Within inhalers, distinctions between dry powder and metered dose designs materially influence materials and end-of-life pathways, while blister and bottle filling machines vary in configuration from multi-lane to single-lane and inline to rotary formats.

Material Type choices intersect with design intent and regulatory constraints and include biodegradable polymers-PBAT, PHA, and PLA-alongside composite materials, glass, metal, and recycled plastics. Technology segmentation highlights additive manufacturing modalities like fused deposition modeling, selective laser sintering, and stereolithography; advanced automation and artificial intelligence for process control; IoT-enabled platforms for telemetry and predictive maintenance; and nascent applications of nanotechnology for material performance.

Application segmentation covers cold chain management, drug delivery across inhalation and parenteral routes, drug manufacturing, packaging with distinctions between primary and secondary formats, and quality control. End user segmentation ranges from contract manufacturing and research organizations to hospitals, pharmaceutical companies, and research institutes, while distribution channels span direct sales, distributors, and e-commerce. Understanding how these segments interrelate enables companies to prioritize product portfolios, align material choices with regulatory paths, and tailor commercial models to distinct buyer needs.

How regional regulatory frameworks, procurement behaviors, and manufacturing ecosystems are influencing the adoption of sustainable device designs across the Americas, Europe Middle East & Africa, and Asia-Pacific

Regional dynamics shape innovation adoption, regulatory expectations, and investment priorities for sustainable pharmaceutical devices. In the Americas, regulatory frameworks and procurement practices are increasingly oriented toward demonstrable environmental performance and supply chain transparency, driving manufacturers to pilot circular packaging and invest in advanced sterilization and quality control equipment that reduce consumable usage. North American clinical networks and large hospital systems often serve as early adopters for devices validated to maintain clinical outcomes while lowering environmental impact.

Across Europe, Middle East & Africa, regulatory harmonization and extended producer responsibility initiatives are influencing design choices, particularly for packaging and end-of-life pathways. European purchasers frequently require lifecycle documentation and end-of-life takeback plans, which encourages manufacturers to incorporate recyclable or biodegradable materials and to partner with reverse-logistics providers. In parallel, markets within the Middle East & Africa demonstrate uneven infrastructure maturity, creating opportunities for modular manufacturing and localized service models that can address cold chain and sterilization challenges at lower scale.

In Asia-Pacific, fast-growing manufacturing capacity, rapid adoption of digital manufacturing technologies, and a dense supplier ecosystem for polymers and electronics enable rapid prototyping and cost-efficient scaling. However, varying regulatory regimes and differing waste management infrastructures across countries require tailored strategies for material selection, sterilization modalities, and distribution models. Sensitivity to regional procurement timelines and local content expectations is essential when deploying new sustainable devices across these diverse geographies.

How supplier partnerships, capability-focused investments, and strategic transactions are redefining competitive advantage among device makers, CMOs, and quality equipment providers

Competitive dynamics among suppliers and OEMs are being reshaped by the simultaneous pressures of sustainability performance and clinical reliability. Leading device manufacturers are investing in integrated design teams that combine materials science, regulatory strategy, and human factors to advance products that satisfy both environmental and clinical requirements. Strategic partnerships between polymer innovators, automation specialists, and sterilization equipment providers are common, as firms seek to accelerate qualification cycles and de-risk supply for novel materials.

At the same time, contract manufacturing organizations and research institutions play a pivotal role in piloting alternative manufacturing processes such as additive manufacturing and in implementing IoT-enabled quality platforms that allow for data-driven validation. Established quality equipment vendors are extending their portfolios to include analytics and non-destructive testing capabilities that minimize scrap and support continuous release models.

Mergers, acquisitions, and minority investments remain tools for acquiring capabilities rapidly, particularly in areas such as biodegradable polymer production, sensor miniaturization, and AI-driven quality control. Companies that succeed will combine product innovation with resilient supply networks, transparent lifecycle data, and commercial models that align incentives across OEMs, suppliers, and large institutional buyers.

Actionable strategic moves for executives to operationalize sustainability through design gating, supplier diversification, digital quality systems, and pilot programs that accelerate adoption

Industry leaders should prioritize a set of actionable initiatives to convert sustainability commitments into competitive advantage. First, embed environmental performance metrics into product requirement documents and design gates so that material selection, recyclability, and lifecycle impacts are considered alongside clinical and usability objectives. Second, accelerate qualification of alternative materials and manufacturing technologies through joint development agreements with polymer innovators and additive manufacturing specialists, thereby shortening time to validated production.

Third, strengthen procurement resilience by diversifying suppliers, qualifying domestic or nearshore sources for critical components, and including trade-compliance provisions in contracts to manage tariff volatility. Fourth, deploy digital quality platforms and sensor-enabled monitoring to reduce waste, enable predictive maintenance of sterilization and packaging equipment, and support data-driven regulatory submissions. Fifth, engage proactively with regulatory bodies and large institutional buyers to co-develop acceptance criteria for new materials and circular packaging models, thus reducing adoption friction.

Finally, design pilot programs that pair clinical performance validation with environmental outcome measurement and commercial pathway testing. These pilots should be structured to generate robust evidence for regulators and purchasers while providing a repeatable template for scaling successful device designs across regions and distribution channels.

Methodological overview detailing interviews, technical consultations, value chain mapping, lifecycle assessment principles, and scenario planning used to produce rigorous, actionable findings

This report synthesizes primary and secondary research to ensure robust, reproducible findings that support strategic decision-making. Primary inputs include structured interviews with senior executives across device OEMs, contract manufacturers, materials providers, and institutional buyers, combined with technical consultations with regulatory and quality assurance experts. These qualitative insights were triangulated with public regulatory guidances, patents, standards for sterilization and packaging, and peer-reviewed literature on biodegradable polymers and additive manufacturing.

Analytical methods include value chain mapping to identify emissions and waste hotspots, capability gap analysis to assess readiness for new materials and technologies, and scenario-based planning to evaluate responses to trade policy shifts and supply disruptions. Where appropriate, lifecycle thinking informed material and packaging recommendations, and cross-functional workshops validated the operational feasibility of proposed interventions. The methodology emphasizes transparency in sources and assumptions and includes appendices with interview protocols, regulatory references, and technology validation criteria to facilitate independent review and replication.

Concluding synthesis emphasizing the strategic necessity of integrated sustainability initiatives to secure clinical integrity, operational resilience, and long-term competitive advantage

Sustainable devices represent both a challenge and an opportunity: the imperative to reduce environmental impact intersects with the need to preserve safety, sterility, and therapeutic efficacy. Companies that approach this transition holistically-aligning design, procurement, manufacturing, and regulatory strategy-will not only meet stakeholder expectations but also capture operational efficiencies through waste reduction, energy optimization, and resilient sourcing. The path forward requires disciplined experimentation, targeted investments in enabling technologies, and collaboration across suppliers, regulators, and large institutional buyers.

Decision-makers should view sustainability initiatives as strategic projects with defined milestones, cross-functional sponsors, and measurable outcomes rather than as peripheral corporate social responsibility activities. By prioritizing pilots that generate both clinical and environmental evidence, and by building modular production capabilities that can scale regionally, organizations can de-risk innovation and accelerate adoption. Ultimately, the companies that integrate circularity into their core product development and commercialization processes will be best positioned to serve evolving healthcare systems while strengthening long-term competitiveness.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of biodegradable microneedle arrays for self-administered drug delivery
  • 5.2. Adoption of reusable connected inhalers with smart dose monitoring and analytics
  • 5.3. Development of compostable single-use syringes using plant-based polymers
  • 5.4. Implementation of closed-loop insulin pumps with energy-efficient wireless charging
  • 5.5. Expansion of recycled plastic packaging for oral solid dosage formulations
  • 5.6. Deployment of modular pharmaceutical manufacturing units powered by renewable energy
  • 5.7. Use of advanced emission capture systems in active pharmaceutical ingredient production

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Sustainable Devices in Pharmaceutical Market, by Product Type

  • 8.1. Delivery Devices
    • 8.1.1. Auto-Injectors
    • 8.1.2. Inhalers
      • 8.1.2.1. Dry Powder
      • 8.1.2.2. Metered Dose
    • 8.1.3. Prefilled Syringes
    • 8.1.4. Transdermal Patches
  • 8.2. IoT & Monitoring Systems
    • 8.2.1. Data Analytics Platforms
    • 8.2.2. Sensors
  • 8.3. Manufacturing Equipment
    • 8.3.1. Coating Machines
    • 8.3.2. Granulation Systems
    • 8.3.3. Tablet Presses
  • 8.4. Packaging Equipment
    • 8.4.1. Blister Packaging Machines
      • 8.4.1.1. Multi-Lane
      • 8.4.1.2. Single-Lane
    • 8.4.2. Bottle Filling Machines
      • 8.4.2.1. Inline
      • 8.4.2.2. Rotary
    • 8.4.3. Cartoning Machines
    • 8.4.4. Sachet Packaging Machines
  • 8.5. Quality Control Equipment
    • 8.5.1. Chromatography Systems
    • 8.5.2. Spectrometers
  • 8.6. Sterilization Equipment
    • 8.6.1. Autoclaves
    • 8.6.2. Ethylene Oxide Sterilizers
    • 8.6.3. Gamma Irradiation Systems

9. Sustainable Devices in Pharmaceutical Market, by Material Type

  • 9.1. Biodegradable Polymers
    • 9.1.1. PBAT
    • 9.1.2. PHA
    • 9.1.3. PLA
  • 9.2. Composite Materials
  • 9.3. Glass
  • 9.4. Metal
  • 9.5. Recycled Plastics

10. Sustainable Devices in Pharmaceutical Market, by Technology

  • 10.1. 3D Printing
    • 10.1.1. Fused Deposition Modeling
    • 10.1.2. Selective Laser Sintering
    • 10.1.3. Stereolithography
  • 10.2. Artificial Intelligence
  • 10.3. Automation
  • 10.4. IoT-Enabled
  • 10.5. Nanotechnology

11. Sustainable Devices in Pharmaceutical Market, by Application

  • 11.1. Cold Chain Management
  • 11.2. Drug Delivery
    • 11.2.1. Inhalation
      • 11.2.1.1. Dry Powder
      • 11.2.1.2. Metered Dose
    • 11.2.2. Parenteral
      • 11.2.2.1. Auto-Injectors
      • 11.2.2.2. Prefilled Syringes
  • 11.3. Drug Manufacturing
  • 11.4. Drug Packaging
    • 11.4.1. Primary Packaging
      • 11.4.1.1. Blister Packaging
      • 11.4.1.2. Bottles
    • 11.4.2. Secondary Packaging
      • 11.4.2.1. Cartons
      • 11.4.2.2. Shrink Wrap
  • 11.5. Quality Control

12. Sustainable Devices in Pharmaceutical Market, by End User

  • 12.1. Contract Manufacturing Organizations
  • 12.2. Contract Research Organizations
  • 12.3. Hospitals & Clinics
  • 12.4. Pharmaceutical Companies
  • 12.5. Research Institutes

13. Sustainable Devices in Pharmaceutical Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Distributors
  • 13.3. E-Commerce

14. Sustainable Devices in Pharmaceutical Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Sustainable Devices in Pharmaceutical Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Sustainable Devices in Pharmaceutical Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Thermo Fisher Scientific Inc.
    • 17.3.2. Danaher Corporation
    • 17.3.3. Merck KGaA
    • 17.3.4. Sartorius AG
    • 17.3.5. Corning Incorporated
    • 17.3.6. Eppendorf AG
    • 17.3.7. GEA Group Aktiengesellschaft
    • 17.3.8. Alfa Laval AB
    • 17.3.9. IMA S.p.A.
    • 17.3.10. Syntegon Technology GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DELIVERY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DELIVERY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DELIVERY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DELIVERY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DELIVERY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DELIVERY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DELIVERY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DELIVERY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY AUTO-INJECTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY AUTO-INJECTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY AUTO-INJECTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY AUTO-INJECTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY AUTO-INJECTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY AUTO-INJECTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY INHALERS, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY INHALERS, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY INHALERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY INHALERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY INHALERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY INHALERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY INHALERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY INHALERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DRY POWDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DRY POWDER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DRY POWDER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DRY POWDER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DRY POWDER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DRY POWDER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY METERED DOSE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY METERED DOSE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY METERED DOSE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY METERED DOSE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY METERED DOSE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY METERED DOSE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PREFILLED SYRINGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PREFILLED SYRINGES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PREFILLED SYRINGES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PREFILLED SYRINGES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PREFILLED SYRINGES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PREFILLED SYRINGES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TRANSDERMAL PATCHES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TRANSDERMAL PATCHES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TRANSDERMAL PATCHES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TRANSDERMAL PATCHES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY IOT & MONITORING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY IOT & MONITORING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY IOT & MONITORING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY IOT & MONITORING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY IOT & MONITORING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY IOT & MONITORING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY IOT & MONITORING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY IOT & MONITORING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DATA ANALYTICS PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DATA ANALYTICS PLATFORMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DATA ANALYTICS PLATFORMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DATA ANALYTICS PLATFORMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DATA ANALYTICS PLATFORMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DATA ANALYTICS PLATFORMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SENSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SENSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SENSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SENSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SENSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SENSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MANUFACTURING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MANUFACTURING EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MANUFACTURING EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MANUFACTURING EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MANUFACTURING EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MANUFACTURING EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MANUFACTURING EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MANUFACTURING EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COATING MACHINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COATING MACHINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COATING MACHINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COATING MACHINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COATING MACHINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COATING MACHINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GRANULATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GRANULATION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GRANULATION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GRANULATION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GRANULATION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GRANULATION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TABLET PRESSES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TABLET PRESSES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TABLET PRESSES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TABLET PRESSES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TABLET PRESSES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TABLET PRESSES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PACKAGING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PACKAGING EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PACKAGING EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PACKAGING EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PACKAGING EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PACKAGING EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PACKAGING EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PACKAGING EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BLISTER PACKAGING MACHINES, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BLISTER PACKAGING MACHINES, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BLISTER PACKAGING MACHINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BLISTER PACKAGING MACHINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BLISTER PACKAGING MACHINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BLISTER PACKAGING MACHINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BLISTER PACKAGING MACHINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BLISTER PACKAGING MACHINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MULTI-LANE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MULTI-LANE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MULTI-LANE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MULTI-LANE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MULTI-LANE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MULTI-LANE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SINGLE-LANE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SINGLE-LANE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SINGLE-LANE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SINGLE-LANE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SINGLE-LANE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SINGLE-LANE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BOTTLE FILLING MACHINES, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BOTTLE FILLING MACHINES, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BOTTLE FILLING MACHINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BOTTLE FILLING MACHINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BOTTLE FILLING MACHINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BOTTLE FILLING MACHINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BOTTLE FILLING MACHINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BOTTLE FILLING MACHINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY INLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY INLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY INLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY INLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY INLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY INLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY ROTARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY ROTARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY ROTARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY ROTARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY ROTARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY ROTARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY CARTONING MACHINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY CARTONING MACHINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY CARTONING MACHINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY CARTONING MACHINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY CARTONING MACHINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY CARTONING MACHINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SACHET PACKAGING MACHINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SACHET PACKAGING MACHINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SACHET PACKAGING MACHINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SACHET PACKAGING MACHINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SACHET PACKAGING MACHINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SACHET PACKAGING MACHINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY QUALITY CONTROL EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY QUALITY CONTROL EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY QUALITY CONTROL EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY QUALITY CONTROL EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY QUALITY CONTROL EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY QUALITY CONTROL EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY QUALITY CONTROL EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY QUALITY CONTROL EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SPECTROMETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SPECTROMETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SPECTROMETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SPECTROMETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SPECTROMETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SPECTROMETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY STERILIZATION EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY STERILIZATION EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY STERILIZATION EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY STERILIZATION EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY STERILIZATION EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY STERILIZATION EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY STERILIZATION EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY STERILIZATION EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY AUTOCLAVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY AUTOCLAVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY AUTOCLAVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY AUTOCLAVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY AUTOCLAVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY AUTOCLAVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY ETHYLENE OXIDE STERILIZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY ETHYLENE OXIDE STERILIZERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY ETHYLENE OXIDE STERILIZERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY ETHYLENE OXIDE STERILIZERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY ETHYLENE OXIDE STERILIZERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY ETHYLENE OXIDE STERILIZERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GAMMA IRRADIATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GAMMA IRRADIATION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GAMMA IRRADIATION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GAMMA IRRADIATION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GAMMA IRRADIATION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GAMMA IRRADIATION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PBAT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PBAT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PBAT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PBAT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PBAT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PBAT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PHA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PHA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PHA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PHA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PHA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PHA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PLA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PLA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PLA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PLA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PLA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PLA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COMPOSITE MATERIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COMPOSITE MATERIALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COMPOSITE MATERIALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COMPOSITE MATERIALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COMPOSITE MATERIALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COMPOSITE MATERIALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GLASS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GLASS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GLASS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GLASS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GLASS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GLASS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY METAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY METAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY METAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY METAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY METAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY METAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY RECYCLED PLASTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY RECYCLED PLASTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY RECYCLED PLASTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY RECYCLED PLASTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY RECYCLED PLASTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY RECYCLED PLASTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY 3D PRINTING, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY 3D PRINTING, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY 3D PRINTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY 3D PRINTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY 3D PRINTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY 3D PRINTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY 3D PRINTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY 3D PRINTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY FUSED DEPOSITION MODELING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL SUSTAINABLE DEVICES IN PHARMACEU